These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 16123773

  • 41. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF.
    Neurosci Lett; 2009 Feb 27; 451(3):257-60. PubMed ID: 19146920
    [Abstract] [Full Text] [Related]

  • 42. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.
    Rohde LA, Roman T, Szobot C, Cunha RD, Hutz MH, Biederman J.
    Synapse; 2003 May 27; 48(2):87-9. PubMed ID: 12619042
    [Abstract] [Full Text] [Related]

  • 43. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.
    Arch Gen Psychiatry; 2007 Aug 27; 64(8):932-40. PubMed ID: 17679638
    [Abstract] [Full Text] [Related]

  • 44. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.
    Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH.
    Pharmacogenetics; 2002 Aug 27; 12(6):497-9. PubMed ID: 12172219
    [Abstract] [Full Text] [Related]

  • 45. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB, Klorman R, Thatcher JE, Borgstedt AD.
    J Am Acad Child Adolesc Psychiatry; 2006 Jul 27; 45(7):808-16. PubMed ID: 16832317
    [Abstract] [Full Text] [Related]

  • 46. Dopamine transporter genotype predicts attentional asymmetry in healthy adults.
    Newman DP, O'Connell RG, Nathan PJ, Bellgrove MA.
    Neuropsychologia; 2012 Oct 27; 50(12):2823-2829. PubMed ID: 22940645
    [Abstract] [Full Text] [Related]

  • 47. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
    Mick E, Biederman J, Spencer T, Faraone SV, Sklar P.
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec 05; 141B(8):890-4. PubMed ID: 16917950
    [Abstract] [Full Text] [Related]

  • 48. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.
    Eur Neuropsychopharmacol; 2013 Dec 05; 23(12):1714-23. PubMed ID: 23731497
    [Abstract] [Full Text] [Related]

  • 49. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V, Rovaris DL, Victor MM, Grevet EH, Rohde LA, Bau CH.
    Eur Neuropsychopharmacol; 2013 Jun 05; 23(6):555-60. PubMed ID: 22709890
    [Abstract] [Full Text] [Related]

  • 50. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.
    Cheon KA, Jun JY, Cho DY.
    Int Clin Psychopharmacol; 2008 Sep 05; 23(5):291-8. PubMed ID: 18703939
    [Abstract] [Full Text] [Related]

  • 51. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD, Yun SW, Chung U, Kim TH, Park JH, Park IH, Han DH.
    Hum Psychopharmacol; 2016 Mar 05; 31(2):76-82. PubMed ID: 26756111
    [Abstract] [Full Text] [Related]

  • 52. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms.
    Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M.
    J Pediatr; 2008 Feb 05; 152(2):263-9. PubMed ID: 18206700
    [Abstract] [Full Text] [Related]

  • 53. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J, Romanos M, Ettinger U.
    Pharmacogenomics J; 2014 Feb 05; 14(1):77-84. PubMed ID: 23588108
    [Abstract] [Full Text] [Related]

  • 54. DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.
    Ding K, Yang J, Reynolds GP, Chen B, Shao J, Liu R, Qian Q, Liu H, Yang R, Wen J, Kang C.
    World J Biol Psychiatry; 2017 Jun 05; 18(4):291-299. PubMed ID: 27676100
    [Abstract] [Full Text] [Related]

  • 55. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
    Agudelo JA, Gálvez JM, Fonseca DJ, Mateus HE, Talero-Gutiérrez C, Velez-Van-Meerbeke A.
    Neurologia; 2015 Apr 05; 30(3):137-43. PubMed ID: 24461309
    [Abstract] [Full Text] [Related]

  • 56. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, Yamagata T, Momoi MY, Watanabe E.
    Clin Neurophysiol; 2012 Jun 05; 123(6):1147-57. PubMed ID: 22088661
    [Abstract] [Full Text] [Related]

  • 57. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P, Kodesh A, Weizman A.
    Clin Neuropharmacol; 2013 Jun 05; 36(5):141-5. PubMed ID: 24045603
    [Abstract] [Full Text] [Related]

  • 58. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
    Kim BN, Kim JW, Hong SB, Cho SC, Shin MS, Yoo HJ.
    Behav Brain Funct; 2010 Oct 07; 6():57. PubMed ID: 20929549
    [Abstract] [Full Text] [Related]

  • 59. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.
    Albrecht B, Brandeis D, Uebel-von Sandersleben H, Valko L, Heinrich H, Xu X, Drechsler R, Heise A, Kuntsi J, Müller UC, Asherson P, Steinhausen HC, Rothenberger A, Banaschewski T.
    J Child Psychol Psychiatry; 2014 Aug 07; 55(8):914-23. PubMed ID: 24521003
    [Abstract] [Full Text] [Related]

  • 60. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, Rapoport JL.
    Arch Gen Psychiatry; 2007 Aug 07; 64(8):921-31. PubMed ID: 17679637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.